Royal Society of Chemistry, Chemical Communications, 28(52), p. 5045-5048, 2016
DOI: 10.1039/c6cc01744d
Full text: Download
Synthetic tripeptide based noncytotoxic hydrogelators have been discovered for releasing an anticancer drug at physiological pH and temparature. Interestingly, gel stiffness, drug release capacity and proteolytic stability of these hydrogels has been sucessfully modulated by incorporating D-amino acid residues, indicating their potential use for drug delivery in future.